Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study.
about
Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysisMortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009Substance use disorders, psychiatric disorders, and mortality after release from prison: a nationwide longitudinal cohort study.A randomized pilot clinical trial to evaluate the efficacy of Community Reinforcement and Family Training for Treatment Retention (CRAFT-T) for improving outcomes for patients completing opioid detoxification.How can health services effectively meet the health needs of homeless people?Pharmacological strategies for detoxification.Risk factors for recent nonfatal overdose among HIV-infected Russians who inject drugs.Associations among pain, non-medical prescription opioid use, and drug overdose history.Social-structural factors influencing periods of injection cessation among marginalized youth who inject drugs in Vancouver, Canada: an ethno-epidemiological study.Understanding drug-related mortality in released prisoners: a review of national coronial records.Rapid opiate detoxification and antagonist induction under general anaesthesia or intravenous sedation is humane, sometimes essential and should always be an option. Three illustrative case reports involving diabetes and epilepsy and a review of theNon-fatal overdose and subsequent drug treatment among injection drug users.Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007.Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study.A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.Just call it "treatment".High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug usersCommunity correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices.Do young heroin users in Madrid, Barcelona and Seville have sufficient knowledge of the risk factors for unintentional opioid overdose?Injecting drug users in Scotland, 2006: Listing, number, demography, and opiate-related death-ratesDeterminants of overdose incidents among illicit opioid users in 5 Canadian cities.Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England.Social and structural aspects of the overdose risk environment in St. Petersburg, Russia.Interim methadone treatment: impact on arrests.Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists.Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?Would legalizing illicit opioids reduce overdose fatalities? Implications from a natural experiment.Suicide Risk in Young Men and Women After Substance Intoxication.Development and initial testing of a tailored telephone intervention delivered by peers to prevent recurring opioid-overdoses (TTIP-PRO).Heroin overdose.Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs.Acute pain management in the opioid-tolerant patient.Overdose education and naloxone distribution for veterans with opioid use disorder: Results from a pilot initiative.Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths.Loss of tolerance and overdose mortality with detoxification: results of study need clarification.Loss of tolerance and overdose mortality with detoxification: deaths have been associated with interventions.Loss of tolerance and overdose mortality with detoxification: abstinence is a valid choice.
P2860
Q28397248-D52489C2-CCBB-4D1D-9E58-82FF06D4EE74Q28468540-E9E825B5-16B6-47F5-B88F-D918D24A1465Q30387588-96D5E18F-3FC2-424D-B490-C55F9A66B713Q30578204-B42D94A0-5D67-4915-B538-ACA7C973A964Q33239786-B376C21E-7905-45EC-9F3F-028D579085BCQ33582092-237E61E3-6BAD-4EA0-AF9D-7D56254ACCB6Q33691974-1FA96803-49E8-4DDA-8644-8E7A87C94BD3Q33724605-080F2619-61BC-4690-A1B2-E72534C0B3BEQ33768352-F367E495-F27B-4414-97D3-C9CEA60AE855Q34219932-3AA2BAFF-F722-4BF3-91EF-A1D63E57E9ADQ34371727-3B740921-0A3E-43B5-9CB3-1CAB21120CFBQ34470475-A53B8D90-9083-4B81-B103-EED509362070Q34563969-A5F80831-3553-48E7-9148-2294AB1AD50AQ34984833-D99F108A-C64B-4D66-A3D9-1261DEDACE8FQ35135608-00476A5D-0EE4-4AB6-99B4-BC5DC0FBCF4DQ35751870-802CC2BF-331C-4C6C-8071-DD06E14CE19EQ36426961-F08DAB3F-FE7F-41CD-8641-BCD74B615CA8Q36728346-30605459-8E31-4005-B6B0-CE5FA379D46EQ36733932-79494942-C64E-4D02-8E68-06781D04465BQ36774534-39FB2775-5E01-40DA-B0FF-19AD46460EECQ36856141-7558F62A-C247-4882-B595-5F3AA3B5CC88Q36879835-A6ED5D2A-88EE-454F-B109-5A823FF6DC66Q36988754-AA402270-DFF1-4D22-9706-3492D4675886Q37106422-DE739E14-8508-441A-863E-60A6CC89D04FQ37227577-24BC098B-3B28-411E-8DB0-81AD467A469EQ37234887-B67FD54B-158F-42B2-9E02-F77B565AC5FEQ37309608-A7C92A4C-F842-4728-B065-06ACD5A4698EQ37698941-D7099764-1853-4DC0-B405-4D76133C0C2AQ38181184-DB420D58-FF91-4C23-BEF8-3048A2CC8F2BQ38679315-E7216C85-6FA9-4A07-A49F-B91F0631C80FQ38891489-F3F9B473-71C8-42ED-93CD-9EDA6D7B15E1Q38924356-8713500C-15DE-4D32-BF0A-C2EE923D3428Q39138996-ED68F941-0F4C-4D7F-8A0F-1DA831FC071BQ39239261-16E7FF79-F7D1-41A3-A37D-55B05220A022Q39332610-C5D9FFF0-BD65-4C79-A32B-69F63B2B8458Q40012736-DC536784-582E-43F3-91D1-700CD24009FEQ40870164-6D9E651A-5CB3-41B1-A9A3-F84FEFCAC843Q42785259-799C736F-DE35-42D9-9CEA-6059F73B22F3Q42785263-3F68B5A3-43EB-4B26-A0D3-07C00D999871Q42785267-8B2D0346-9CD0-40FB-8E9E-6ADDB0DBA4C1
P2860
Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Loss of tolerance and overdose ...... toxification: follow up study.
@ast
Loss of tolerance and overdose ...... toxification: follow up study.
@en
Loss of tolerance and overdose ...... toxification: follow up study.
@nl
type
label
Loss of tolerance and overdose ...... toxification: follow up study.
@ast
Loss of tolerance and overdose ...... toxification: follow up study.
@en
Loss of tolerance and overdose ...... toxification: follow up study.
@nl
prefLabel
Loss of tolerance and overdose ...... toxification: follow up study.
@ast
Loss of tolerance and overdose ...... toxification: follow up study.
@en
Loss of tolerance and overdose ...... toxification: follow up study.
@nl
P2093
P2860
P356
P1433
P1476
Loss of tolerance and overdose ...... toxification: follow up study.
@en
P2093
David Best
Jenny Bearn
Jim McCambridge
John Strang
Michael Gossop
Tracy Beswick
P2860
P304
P356
10.1136/BMJ.326.7396.959
P407
P577
2003-05-01T00:00:00Z